TBC1D15 has been identified as a putative Rab7a inactivator (GAP), since it accelerates GTP hydrolysis by Rab7a in vitro and its overexpression disrupts lysosomal morphology and blocks growth factor withdrawal-induced death in cancer cells [33]. This evidence concerns the gene RAB7A and cancer.